The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer ; volume:26 ; number:1 ; day:20 ; month:2 ; year:2024 ; pages:1-11 ; date:12.2024
Breast cancer research ; 26, Heft 1 (20.2.2024), 1-11, 12.2024
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Heesch, Amelie
Florea, Alexandru
Maurer, Jochen
Habib, Pardes
Werth, Laura S.
Hansen, Thomas
Stickeler, Elmar
Sahnoun, Sabri E. M.
Mottaghy, Felix
Morgenroth, Agnieszka
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01787-9
- URN
-
urn:nbn:de:101:1-2404291023231.636109535521
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heesch, Amelie
- Florea, Alexandru
- Maurer, Jochen
- Habib, Pardes
- Werth, Laura S.
- Hansen, Thomas
- Stickeler, Elmar
- Sahnoun, Sabri E. M.
- Mottaghy, Felix
- Morgenroth, Agnieszka
- SpringerLink (Online service)
Other Objects (12)
The Potential of PSMA as a Vascular Target in TNBC
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
The Potential of PSMA as a Vascular Target in TNBC
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
The Potential of PSMA as a Vascular Target in TNBC
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?
Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer